Relay Therapeutics, Inc. (RLAY)
NASDAQ: RLAY · IEX Real-Time Price · USD
6.64
+0.13 (2.00%)
At close: May 17, 2024, 4:00 PM
6.60
-0.04 (-0.60%)
After-hours: May 17, 2024, 6:14 PM EDT

Relay Therapeutics Market Cap

Relay Therapeutics has a market cap or net worth of $881.41 million as of May 17, 2024. Its market cap has decreased by -30.04% in one year.

Market Cap
881.41M
Enterprise Value
181.40M
1-Year Change
-30.04%
Ranking
Category
Stock Price
$6.64

Market Cap Chart

Since July 16, 2020, Relay Therapeutics's market cap has decreased from $3.05B to $881.41M, a decrease of -71.05%. That is a compound annual growth rate of -27.60%.

History

DateMarket Cap% Change
May 17, 2024881.40M2.00%
May 16, 2024864.10M-4.20%
May 15, 2024902.00M6.85%
May 14, 2024844.20M-0.94%
May 13, 2024852.20M-
May 10, 2024852.20M1.74%
May 9, 2024837.60M-3.07%
May 8, 2024864.10M-3.42%
May 7, 2024894.70M-4.53%
May 6, 2024937.20M0.29%
May 3, 2024934.50M-0.56%
May 2, 2024939.80M7.57%
May 1, 2024873.70M2.15%
Apr 30, 2024855.30M-1.06%
Apr 29, 2024864.50M3.46%
Apr 26, 2024835.60M3.49%
Apr 25, 2024807.40M-3.07%
Apr 24, 2024833.00M7.62%
Apr 23, 2024774.00M-0.83%
Apr 22, 2024780.50M-0.17%
Apr 19, 2024781.80M-2.46%
Apr 18, 2024801.50M-1.61%
Apr 17, 2024814.60M-7.86%
Apr 16, 2024884.10M-1.33%
Apr 15, 2024896.00M-2.84%
View and export this data all the way back to 2020. Sign Up Today.

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding
Full Definition

Related Stocks

Company Market Cap
Centessa Pharmaceuticals 891.28M
ARS Pharmaceuticals 883.69M
Perspective Therapeutics 883.31M
Abivax 880.84M
ProKidney 876.98M
89bio 872.67M
Immunome 870.15M
Healthcare Services Group 861.30M
Market Cap Rankings